Atlas Trials

Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients

Clinical trial NCT06951737 · COMPLETED

Trial details

NCT number
NCT06951737
Sponsor
Bursa Postgraduate Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes MellitusAtrial Fibrillation (AF)
Start date
2022-10-02
Primary completion
2024-04-02
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.